| Product Code: ETC9550064 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The blood plasma derivative import market in Sweden experienced a significant increase in concentration in 2024, moving from low to moderate levels as indicated by the Herfindahl-Hirschman Index (HHI). The top exporting countries to Sweden in 2024 were Belgium, Netherlands, Germany, Switzerland, and Ireland, showcasing a diverse mix of suppliers. The impressive Compound Annual Growth Rate (CAGR) of 18.43% from 2020 to 2024, coupled with a notable growth rate of 26.65% from 2023 to 2024, reflects the strong momentum and increasing demand for blood plasma derivatives in the Swedish market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Blood Plasma Derivative Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Blood Plasma Derivative Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Blood Plasma Derivative Market - Industry Life Cycle |
3.4 Sweden Blood Plasma Derivative Market - Porter's Five Forces |
3.5 Sweden Blood Plasma Derivative Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sweden Blood Plasma Derivative Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Sweden Blood Plasma Derivative Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Sweden Blood Plasma Derivative Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in demand for plasma-derived therapies due to rising prevalence of chronic diseases |
4.2.2 Technological advancements in plasma fractionation techniques leading to improved product quality |
4.2.3 Growing awareness about the benefits of plasma derivatives among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for plasma collection and processing |
4.3.2 Limited availability of plasma donors leading to supply shortage |
4.3.3 High cost associated with plasma-derived products affecting affordability for patients |
5 Sweden Blood Plasma Derivative Market Trends |
6 Sweden Blood Plasma Derivative Market, By Types |
6.1 Sweden Blood Plasma Derivative Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Blood Plasma Derivative Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Sweden Blood Plasma Derivative Market Revenues & Volume, By Albumin, 2021- 2031F |
6.1.4 Sweden Blood Plasma Derivative Market Revenues & Volume, By Factor VII, 2021- 2031F |
6.1.5 Sweden Blood Plasma Derivative Market Revenues & Volume, By Factor IX concentrate, 2021- 2031F |
6.1.6 Sweden Blood Plasma Derivative Market Revenues & Volume, By Anti-coagulation factor, 2021- 2031F |
6.1.7 Sweden Blood Plasma Derivative Market Revenues & Volume, By Rh immunoglobulin, 2021- 2031F |
6.1.8 Sweden Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sweden Blood Plasma Derivative Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Sweden Blood Plasma Derivative Market Revenues & Volume, By Immunodeficiency Diseases, 2021- 2031F |
6.2.3 Sweden Blood Plasma Derivative Market Revenues & Volume, By Bleeding Disorders, 2021- 2031F |
6.2.4 Sweden Blood Plasma Derivative Market Revenues & Volume, By Liver Conditions, 2021- 2031F |
6.2.5 Sweden Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sweden Blood Plasma Derivative Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Sweden Blood Plasma Derivative Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Sweden Blood Plasma Derivative Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Sweden Blood Plasma Derivative Market Revenues & Volume, By Transfusion Centers, 2021- 2031F |
7 Sweden Blood Plasma Derivative Market Import-Export Trade Statistics |
7.1 Sweden Blood Plasma Derivative Market Export to Major Countries |
7.2 Sweden Blood Plasma Derivative Market Imports from Major Countries |
8 Sweden Blood Plasma Derivative Market Key Performance Indicators |
8.1 Percentage of plasma-derived products meeting regulatory standards for quality and safety |
8.2 Number of new plasma collection centers opened to address supply shortage |
8.3 Patient satisfaction levels with plasma-derived therapies |
8.4 Research and development investment in new plasma fractionation technologies |
8.5 Number of educational campaigns conducted to increase awareness about plasma derivatives |
9 Sweden Blood Plasma Derivative Market - Opportunity Assessment |
9.1 Sweden Blood Plasma Derivative Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sweden Blood Plasma Derivative Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Sweden Blood Plasma Derivative Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Sweden Blood Plasma Derivative Market - Competitive Landscape |
10.1 Sweden Blood Plasma Derivative Market Revenue Share, By Companies, 2024 |
10.2 Sweden Blood Plasma Derivative Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here